Trial Outcomes & Findings for Evaluation of Physiological Variables and Detection of Blood Loss Using the Zynex Fluid Monitoring System, Model CM-1600 (NCT NCT05463198)

NCT ID: NCT05463198

Last Updated: 2024-08-13

Results Overview

The objective of this study is to determine if manual blood loss of up to 500mL of blood can be identified using the non-invasive Zynex CM-1600. This will be measured by determining the percent change in Relative Index (RI) before and after the Blood Draw. The RI is an investigational value which utilizes proprietary algorithms to combine the changes of multiple measured parameters (utilizing a weighted summation of percent change values) which are indicative of relative changes in fluid volume in adult patients into a single value. The RI is a unitless value with no set minimum or maximum, where 100 is a patient's baseline. Based on the nature of the RI itself, a direct interpretation of a positive or negative outcome cannot be derived from the absolute value, instead it could be used to monitor trending of a patient's parameters relative to their baseline.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

351 participants

Primary outcome timeframe

Recovery period following donation (10 minutes)

Results posted on

2024-08-13

Participant Flow

Participant milestones

Participant milestones
Measure
Blood Loss
CM-1600: Subjects undergoing blood donation will be connected to the CM-1600 device.
Overall Study
STARTED
351
Overall Study
COMPLETED
314
Overall Study
NOT COMPLETED
37

Reasons for withdrawal

Reasons for withdrawal
Measure
Blood Loss
CM-1600: Subjects undergoing blood donation will be connected to the CM-1600 device.
Overall Study
Withdrawal by Subject
19
Overall Study
Procedure Notes Missing
18

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Blood Loss
n=314 Participants
CM-1600: Subjects undergoing blood donation will be connected to the CM-1600 device.
Age, Continuous
43.8 years
STANDARD_DEVIATION 21.4 • n=314 Participants
Sex: Female, Male
Female
193 Participants
n=314 Participants
Sex: Female, Male
Male
121 Participants
n=314 Participants
Region of Enrollment
United States
314 participants
n=314 Participants

PRIMARY outcome

Timeframe: Recovery period following donation (10 minutes)

Population: 18 subjects were unevaluable; 19 subjects were withdrawn

The objective of this study is to determine if manual blood loss of up to 500mL of blood can be identified using the non-invasive Zynex CM-1600. This will be measured by determining the percent change in Relative Index (RI) before and after the Blood Draw. The RI is an investigational value which utilizes proprietary algorithms to combine the changes of multiple measured parameters (utilizing a weighted summation of percent change values) which are indicative of relative changes in fluid volume in adult patients into a single value. The RI is a unitless value with no set minimum or maximum, where 100 is a patient's baseline. Based on the nature of the RI itself, a direct interpretation of a positive or negative outcome cannot be derived from the absolute value, instead it could be used to monitor trending of a patient's parameters relative to their baseline.

Outcome measures

Outcome measures
Measure
Blood Loss
n=314 Participants
CM-1600: Subjects undergoing blood donation will be connected to the CM-1600 device.
Change in the Relative Index (RI) After Minor Blood Loss (e.g., 500mL)
2.9 Percent change in RI
Standard Deviation 151.1

Adverse Events

Blood Loss

Serious events: 0 serious events
Other events: 4 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Blood Loss
n=351 participants at risk
CM-1600: Subjects undergoing blood donation will be connected to the CM-1600 device.
General disorders
Light-headedness due to blood donation procedure
1.1%
4/351 • Number of events 4 • Adverse Events were recorded during subject participation and for 24hrs after participation was complete, a total of up to 27hrs.

Additional Information

ZMS Clinical

Zynex Monitoring Solutions

Phone: 800-495-6670

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place